SCHEMBL23969474

SCHEMBL23969474

CC(=O)N1CCN(c2ncc(CC(=O)O)cn2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.50
ACHE P22303 3/20 0.49
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
AOC3 Q16853 2/20 0.45
PTPN11 Q06124 1/20 0.45
ATM Q13315 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CKS1B P61024 1/20 0.43
SKP1 P63208 1/20 0.43
SKP2 Q13309 1/20 0.43
SMO Q99835 1/20 0.43
POLB P06746 1/20 0.42
GBA1 P04062 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20425022 0.98 RORC (0.49) RORCACHEMEN1KMT2AAOC3
SCHEMBL30722324 0.85 MEN1 (0.49) RORCACHEMEN1KMT2AAOC3
SCHEMBL10063435 0.84 MEN1 (0.50) RORCACHEMEN1KMT2AAOC3
SCHEMBL27767066 0.84 HDAC3 (0.50) ACHEMEN1KMT2ANPC1RAB9A
SCHEMBL20425037 0.82 GPR119 (0.51) RORCACHEMEN1KMT2AAOC3
SCHEMBL34462083 0.81 RORC (0.50) RORCACHEMEN1KMT2AAOC3
SCHEMBL27793296 0.81 GPR119 (0.61) ACHEPTPN11CKS1BSKP1SKP2
SCHEMBL3607524 0.80 POLB (0.66) AOC3PTPN11POLBHDAC6KDM4E
SCHEMBL20425044 0.79 KDM4E (0.48) AOC3PTPN11NPC1RAB9APOLB
SCHEMBL29562721 0.79 KDM4E (0.66) RORCMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3573974-B1 RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2024-09-18 EP disclosed
US-11974997-B2 RORgamma modulators and uses thereof GENFIT (FR) 2024-05-07 US disclosed
US-20220133716-A1 RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2022-05-05 US disclosed
US-20220133716-A1 RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2022-05-05 US disclosed
US-11160801-B2 RORgamma modulators and uses thereof GENFIT (FR) 2021-11-02 US disclosed
US-11160801-B2 RORgamma modulators and uses thereof GENFIT (FR) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220133716-A1 RORGAMMA MODULATORS AND USES THEREOF RORB, RORC, RORA RORC 2/4885ACHE 4073/4885MEN1 3748/4885
US-11974997-B2 RORgamma modulators and uses thereof RORB, RORC, RORA RORC 2/4885ACHE 4073/4885MEN1 3748/4885
US-11160801-B2 RORgamma modulators and uses thereof RORB, RORC, RORA RORC 2/4885ACHE 4073/4885MEN1 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.